Literature DB >> 23290730

Obesity and diabetic kidney disease.

Christine Maric-Bilkan1.   

Abstract

Obesity and diabetes are major causes of CKD and ESRD, and are thus enormous health concerns worldwide. Both obesity and diabetes, along with other elements of the metabolic syndrome including hypertension, are highly interrelated and contribute to the development and progression of renal disease. Studies show that multiple factors act in concert to initially cause renal vasodilation, glomerular hyperfiltration, and albuminuria, leading to the development of glomerulopathy. The coexistence of hypertension contributes to the disease progression, which, if not treated, may lead to ESRD. Although early intervention and management of body weight, hyperglycemia, and hypertension are imperative, novel therapeutic approaches are also necessary to reduce the high morbidity and mortality associated with both obesity-related and diabetes-related renal disease.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23290730      PMCID: PMC3539140          DOI: 10.1016/j.mcna.2012.10.010

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  112 in total

Review 1.  Synergy of low nephron number and obesity: a new focus on hyperfiltration nephropathy.

Authors:  Manuel Praga
Journal:  Nephrol Dial Transplant       Date:  2005-10-13       Impact factor: 5.992

Review 2.  AT(1) receptors and control of blood pressure: the kidney and more...

Authors:  Steven D Crowley; Susan B Gurley; Thomas M Coffman
Journal:  Trends Cardiovasc Med       Date:  2007-01       Impact factor: 6.677

3.  Systematic kidney disease management in a population with diabetes mellitus: turning the tide of kidney failure.

Authors:  Hugh C Rayner; Lee Hollingworth; Robert Higgins; Simon Dodds
Journal:  BMJ Qual Saf       Date:  2011-06-30       Impact factor: 7.035

4.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

5.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2012-01-17       Impact factor: 56.272

6.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

7.  Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.

Authors:  Jussara M do Carmo; Lakshmi S Tallam; John V Roberts; Elizabeth L Brandon; John Biglane; Alexandre A da Silva; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-15       Impact factor: 3.619

8.  Adenosine A(1) receptors determine glomerular hyperfiltration and the salt paradox in early streptozotocin diabetes mellitus.

Authors:  Volker Vallon; Jana Schroth; Joseph Satriano; Roland C Blantz; Scott C Thomson; Timo Rieg
Journal:  Nephron Physiol       Date:  2009-03-10

Review 9.  Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells.

Authors:  Jia L Zhuo; Xiao C Li
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2007-03       Impact factor: 1.636

10.  Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin.

Authors:  Ke Ma; Agatha Cabrero; Pradip K Saha; Hideto Kojima; Lan Li; Benny Hung-Junn Chang; Antoni Paul; Lawrence Chan
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

View more
  53 in total

Review 1.  Diagnostic and prognostic utility of non-invasive imaging in diabetes management.

Authors:  Cristina Barsanti; Francesca Lenzarini; Claudia Kusmic
Journal:  World J Diabetes       Date:  2015-06-25

Review 2.  Impact of bariatric surgery on cardiovascular and renal complications of diabetes: a focus on clinical outcomes and putative mechanisms.

Authors:  William P Martin; Neil G Docherty; Carel W Le Roux
Journal:  Expert Rev Endocrinol Metab       Date:  2018-09-19

Review 3.  Immunologic and endocrine functions of adipose tissue: implications for kidney disease.

Authors:  Qingzhang Zhu; Philipp E Scherer
Journal:  Nat Rev Nephrol       Date:  2017-12-04       Impact factor: 28.314

Review 4.  Nephropathy in youth and young adults with type 2 diabetes.

Authors:  Carolina Solis-Herrera; Curtis L Triplitt; Jane L Lynch
Journal:  Curr Diab Rep       Date:  2014-02       Impact factor: 4.810

Review 5.  Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease.

Authors:  Joanne E Murphy-Ullrich; Mark J Suto
Journal:  Matrix Biol       Date:  2017-12-27       Impact factor: 11.583

Review 6.  Obesity in kidney disease: A heavyweight opponent.

Authors:  Raphael Jose Ferreira Felizardo; Marina Burgos da Silva; Cristhiane Favero Aguiar; Niels Olsen Saraiva Câmara
Journal:  World J Nephrol       Date:  2014-08-06

7.  Effects of Na/K-ATPase and its ligands on bone marrow stromal cell differentiation.

Authors:  Moustafa Sayed; Christopher A Drummond; Kaleigh L Evans; Steven T Haller; Jiang Liu; Zijian Xie; Jiang Tian
Journal:  Stem Cell Res       Date:  2014-04-13       Impact factor: 2.020

8.  Clinical and Pathology Findings Associate Consistently with Larger Glomerular Volume.

Authors:  Aleksandar Denic; Jerry Mathew; Venkata V Nagineni; R Houston Thompson; Bradley C Leibovich; Lilach O Lerman; John C Lieske; Mariam P Alexander; Joshua J Augustine; Walter K Kremers; Andrew D Rule
Journal:  J Am Soc Nephrol       Date:  2018-05-22       Impact factor: 10.121

9.  Short-term changes after a weight reduction intervention in advanced diabetic nephropathy.

Authors:  Allon N Friedman; Mary Chambers; Lisa M Kamendulis; Joan Temmerman
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-08       Impact factor: 8.237

10.  Shock wave lithotripsy does not impair renal function in a Swine model of metabolic syndrome.

Authors:  Rajash K Handa; Cynthia D Johnson; Bret A Connors; Andrew P Evan; Carrie L Phillips; Ziyue Liu
Journal:  J Endourol       Date:  2014-11-18       Impact factor: 2.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.